Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients. Show more

Location: 100 Technology Sq Fl 5, Massachusetts, 02139-3585, US | Website: www.magentatx.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$0.76

Open

$0.71

Volume

376,060

Day Range

$0.68 - $0.76

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

2.23%

Institutional Own.

62.64%

Qtr Updated

03/31/24